
How a tightening labor market impacts Biotech and Pharma Manufacturing
With the latest release of employment data from the U.S. Labor Department, it is apparent that, at least in the short term, unemployment is nearing
With the latest release of employment data from the U.S. Labor Department, it is apparent that, at least in the short term, unemployment is nearing
Part Three – Increasing Cost of Innovation The third driver that is triggering the growth of the foundry model in Molecular Diagnostics is the ever
Part Two- Leveraging Commonality The second driver that spawned the growth of the foundry model was the ability to Leverage Commonality. By the mid 1980’s,
Many organizations view their QC program as a necessary evil- required by regulatory bodies and useful primarily to release product. However, defining and building a
Part One – Keeping Pace in Molecular Diagnostics Innovation The foundry model is poised to fundamentally transform the biotechnology and molecular diagnostics sectors. As it
The concept of variabilization, a willful shift from fixed to variable costs, has been around since the late 1990s. First-in-class companies have moved from a